Ask AI
ADA and EASD 2025

CME

Global Perspectives on New Data in Type 2 Diabetes: Congress-to-Clinic Insights From ADA and EASD 2025

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Released: September 30, 2025

Expiration: September 29, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A patient with T2D (A1C 7.9%), obesity (BMI 42 kg/m2), and atherosclerotic cardiovascular disease is taking metformin and sitagliptin. The patient would like to focus on weight loss. Based on recent data, which emerging therapeutic option would likely be most beneficial for this patient?